3rd Quarter - Report

AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS for AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS

Firm
Client
Income
—
Expenses
$127,174
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Sustainable Growth Rate Formula Reform (general); Independent Payment Advisory Board (general); ; FMAP (general);Imaging Accreditation H.R. 4213; H.R. 5618; Medicaid Primary Care Payment (General).

LobbyistCovered position, as disclosed
LUCIA DIVENERE —
ANNA HYDE —
NEVENA MINOR —
JOSEF WEISSFELD —

Contacted: Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); Defense, Dept of (DOD); Health & Human Services, Dept of (HHS); Indian Health Service; Centers For Disease Control & Prevention (CDC); SENATE; Centers For Medicare and Medicaid Services (CMS); White House Office; Food & Drug Administration (FDA); Office of Management & Budget (OMB)

Bills named: H.R. 5618 (111th), H.R. 4213 (111th)

Health Issues HCR

HR.463,The Prevention First Act; Comprehensive Sexuality Education funding (general), Melanie Blocker Stokes MOTHERS Act; H.R. 2427/S. 1050, National HIV/AIDS Strategy (general); H.R. 3312 Preventing Unintended Pregnancies, Reducing the Need for Abortion and Supporting Parents; The Heart for Women Act; H.R. 3652S. 3737, CARE Act; H.R. 5354, GEDI Act. H.R. 3090, Health Equity and Accountability Act; H.R. 2635; Stillbirth (general); Sudden unexpected infant deaths (general); Postpartum Depression (general); Emergency Contraception (general); Pre-existing condition exclusion (general); Gender rating (general); Maternity Coverage (general); S. 1303 Medical Home Demonstration Project; Alternatives to Medical Liability Reform Demonstration Project (general); Young Adult Plans (general); Preventive Care (general); Domestic Violence(general); Prescription Drug Coverage (general); Comparative Effectiveness Research (general); S.1679 Affordable Health Choices Act; Medicaid SCHIP Coverage and Reimbursement; HIV Screening (general); H.R. 3962 Affordable Health Care For America Act; H.R. 2941Gynecological Cancer; Breast Cancer (general); Breastfeeding(general); Medical Liability Reform (general); HR 4386, S. 2904 Emergency Contraception in the Military; Direct Access to Ob-Gyns (general); S. 1742, H.R. 4235 Women's Hospitals Education Equity; National HIV/AIDS Strategy Steps; H.R. 3854 Small Business Financing and Investment Act of 2009; H.R. 4216 Personal Health Record Act of 2009; Abortion (general); H.R. 4872 Health Care and Reconciliation Act of 2010; Health IT (general); Birth Defects(general);Birth Centers (general);Prematurity(general);Obesity (general);Disparities (general);Smoking cessation (general); Prevention & Public Health Trust Fund(general); S.1445 and H.R.3212, Stillbirth and Suid Prevention Education, Awareness Act of 2009,H.R.5462 and S.3479, Birth Defects, Prevention Risk Reduction, Awareness Act of 2010; USDA Dietary Guidelines Advisory Committee Report; H.R. 5690, The Meaningful End to Defensive Medicine and Aimless Lawsuits; S. 422.

LobbyistCovered position, as disclosed
LUCIA DIVENERE —
ANNA HYDE —
NEVENA MINOR —
JOSEF WEISSFELD —

Contacted: White House Office; Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE; Natl Institutes of Health (NIH); Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); Indian Health Service; Office of Management & Budget (OMB); Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES

Bills named: S. 1050 (111th), H.R. 3854 (111th), H.R. 4216 (111th), H.R. 4386 (111th), S. 1445 (111th), H.R. 3090 (111th), H.R. 3652 (111th), H.R. 463 (111th), H.R. 3212 (111th), H.R. 4235 (111th), S. 422 (111th), H.R. 5462 (111th), H.R. 3312 (111th), H.R. 4872 (111th), H.R. 2427 (111th), S. 1303 (111th), H.R. 2635 (111th), S. 3479 (111th), S. 1742 (111th), H.R. 2941 (111th), H.R. 3962 (111th), S. 1679 (111th), H.R. 5690 (111th), H.R. 5354 (111th), S. 2904 (111th)

Budget/Appropriations BUD

Public health Funding for National Institutes of Health (NIH); Health Resources and Services Administration (HRSA); Centers for Disease Control (CDC); Agency for Healthcare Research and Quality (AHRQ) for biomedical research; Comprehensive Sexuality Education funding (general); Affordable birth control; International family planning; Indian Health Services (IHS); Violence Against Women Programs; Office of Adolescent Health;Teen Pregnancy Prevention; Title X Family Planning (HRSA) Maternal Mortality Reviews (CDC); Electronic Birth and Death Records (CDC); National Fetal Infant Mortality Review (HRSA); Obesity Research, Treatment Prevention (HHS); Comparitive Effectiveness Research (AHRQ); Department of Defense (DOD) Ovarian Cancer Research Program; Health Disparities (HHS); Safe Motherhood (CDC); Preterm Research (NIH); Title V Block Grant (HRSA); STD Prevention (CDC).

LobbyistCovered position, as disclosed
LUCIA DIVENERE —
ANNA HYDE —
NEVENA MINOR —
JOSEF WEISSFELD —

Contacted: HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Centers For Disease Control & Prevention (CDC); White House Office; Food & Drug Administration (FDA); Indian Health Service; SENATE; Natl Institutes of Health (NIH); Health Resources & Services Administration (HRSA); Defense, Dept of (DOD); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.